Opinion|Videos|April 4, 2025

Payer and Reimbursement Considerations for Bispecific Therapies

Experts discuss how payer and reimbursement considerations affect access to bispecific therapies in different practice settings.

Video content above is prompted by the following:

How do payer and reimbursement considerations affect access to bispecific therapies in different practice settings?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo